ORG 41841

Drug Profile

ORG 41841

Latest Information Update: 25 Sep 2006

Price : $50

At a glance

  • Originator Organon
  • Class Infertility therapies; Pyrimidines; Small molecules; Thiophenes
  • Mechanism of Action Gonadotropin releasing hormone stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Female infertility

Most Recent Events

  • 25 Sep 2006 No development reported - Phase-I for Female infertility in Netherlands (unspecified route)
  • 16 Sep 2002 Phase-I clinical trials in Female infertility in Netherlands (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top